Axogen provides technology and solutions for restoring feeling and functionality to damaged peripheral nerves. This description is self-described.

Axogen

Domain Not Resolving

HSTS

DNSSEC

Cloudflare CDN

Cloudflare Hosting

Cloudflare Network Error Logging

Microsoft

Gravity Forms

Microsoft Azure

Envoy

Chief Commercial Officer

Eric Sandberg

Area Sales Manager, Chairmans Club, Quota Buster

George Heidacher

Founder

Jeremiah Burke

President, CEO and Chairman of the Board

Karen Zaderej

Stuart Kim

Vice President Regulatory Affairs

Angela Nelson, MBA, RAC(GS)

Vice President, Global Health Economics, Reimbursement and Policy

Ann Thompson

Vice President, Sales

Chris Crisman

Vice President of Sales

Doris Quackenbush

Vice President, Peripheral Nerve Science and Clinical Innovation

Erick DeVinney

Joe Mandato

Paul G. Thomas

Gregory Davault

VP of Marketing

Marc Began

Executive Vice President & General Counsel

Jens Schroeder Kemp

Chief Marketing Officer

Maria Martinez

Chief Human Resources Officer

Siddharth Rao

SVP & CIO, Head of IT, BI & Commercial Ops

Nir Naor

Chief Financial Officer

Jamie Grooms

Director

Kelly Clark

Quality Engineering Intern

Essex Woodlands Healthcare Partners Portfolio Companies

United States Public Companies With More Than 50 Employees

Southern US Companies With More Than $50M in Revenue (Top 10K)

United States Public Companies With More Than $50M in Revenue

AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.

Post-IPO Equity - AxoGen

Debt Financing - AxoGen

PDL Biopharma

Alachua

Florida

United States

North America

AxoGen

Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)

Axogen, Inc. Announces New Leadership Appointments

AxoGen appoint Dale as CEO, Thomas as Chairman

AxoGen Q2 Earnings and Revenues Beat Estimates

Axogen Names Abbott SVP Michael Dale as CEO

Axogen launches Avive+ Soft Tissue Matrix

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

Axogen announces first surgical implant of Avive+ Soft Tissue Matrix

AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates

AxoGen First Quarter 2024 Earnings: Misses Expectations

Canada

Bangladesh

Asia

Australia

Oceania

India

HTML5

Google Fonts

DigiCert

Bootstrap

Microsoft Outlook

jQuery

Google Compute Engine

Google Analytics

Amazon EC2

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

AxoGen, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 30, 2024 9:29 AM	46352639
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 30, 2024 9:29 AM	597d3544
crunchbase trigger	general	Oct 28, 2024 1:50 PM	4785254c
crunchbase profile	general	Oct 29, 2024 9:39 AM	505efaed
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	dc62fb2f
peers	general	Sep 30, 2024 9:29 AM	060fd637
news basic	general	Sep 30, 2024 9:29 AM	0998e26c
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:AXOGENINC

Axogen

Last Close

13.10

22/11 21:00

Market Cap

336.53M

Beta: -

Volume Today

204.37K

Avg: -